This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Soret, J. Articles by Tazi, J. Search for Related Content PubMed PubMed Citation Articles by Soret, J. Articles by Tazi, J.

Altered Serine/Arginine-Rich Protein Phosphorylation and Exonic Enhancer-Dependent Splicing in Mammalian Cells Lacking Topoisomerase I

¹ Institut de Génétique Moléculaire, Centre National de la Recherche Scientifique/UMR5535, and Institut Fédératif de Recherches 122 Montpellier, France;
² Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; and
³ Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/Université Louis Pasteur, C. U. de Strasbourg, France

DNA topoisomerase I (Topo I) specifically phosphorylates arginine-serine-rich (SR proteins) splicing factors and is potentially involved in pre-mRNA-splicing regulation. Using a Topo I-deficient murine B lymphoma-derived subclone (P388-45/C) selected for its resistance to high dosage of the antitumor drug camptothecin, we show that Topo I depletion results in the hypophosphorylation of SR proteins and impairs exonic splicing enhancer (ESE)-dependent but not constitutive splicing. The Affymetrix GeneChip system analysis revealed that several alternatively spliced genes, characterized by small exons and large introns, are down-regulated in Topo I-deficient cells. Given that ectopic expression of green fluorescent protein-Topo I fusion in Topo I-deficient cells restores both wild-type phosphorylation of SR proteins and ESE-dependent splicing, we conclude that Topo I-mediated phosphorylation plays a specific role in ESE-regulated splicing.

This article has been cited by other articles:

				A. Eisenreich, V. Y. Bogdanov, A. Zakrzewicz, A. Pries, S. Antoniak, W. Poller, H.-P. Schultheiss, and U. Rauch Cdc2-Like Kinases and DNA Topoisomerase I Regulate Alternative Splicing of Tissue Factor in Human Endothelial Cells Circ. Res., March 13, 2009; 104(5): 589 - 599. [Abstract] [Full Text] [PDF]

				O. Sordet, A. Goldman, C. Redon, S. Solier, V. A. Rao, and Y. Pommier Topoisomerase I Requirement for Death Receptor-induced Apoptotic Nuclear Fission J. Biol. Chem., August 22, 2008; 283(34): 23200 - 23208. [Abstract] [Full Text] [PDF]

				M. Malanga, A. Czubaty, A. Girstun, K. Staron, and F. R. Althaus Poly(ADP-ribose) Binds to the Splicing Factor ASF/SF2 and Regulates Its Phosphorylation by DNA Topoisomerase I J. Biol. Chem., July 18, 2008; 283(29): 19991 - 19998. [Abstract] [Full Text] [PDF]

				S. Stamm Regulation of Alternative Splicing by Reversible Protein Phosphorylation J. Biol. Chem., January 18, 2008; 283(3): 1223 - 1227. [Abstract] [Full Text] [PDF]

				J. Barbier, M. Dutertre, D. Bittencourt, G. Sanchez, L. Gratadou, P. de la Grange, and D. Auboeuf Regulation of H-ras Splice Variant Expression by Cross Talk between the p53 and Nonsense-Mediated mRNA Decay Pathways Mol. Cell. Biol., October 15, 2007; 27(20): 7315 - 7333. [Abstract] [Full Text] [PDF]

				Z.-H. Miao, A. Player, U. Shankavaram, Y.-H. Wang, D. B. Zimonjic, P. L. Lorenzi, Z.-Y. Liao, H. Liu, T. Shimura, H.-L. Zhang, et al. Nonclassic Functions of Human Topoisomerase I: Genome-Wide and Pharmacologic Analyses Cancer Res., September 15, 2007; 67(18): 8752 - 8761. [Abstract] [Full Text] [PDF]

				V. Locato, A. Balestrazzi, L. De Gara, and D. Carbonera Reduced expression of top1{beta} gene induces programmed cell death and alters ascorbate metabolism in Daucus carota cultured cells J. Exp. Bot., May 1, 2006; 57(8): 1667 - 1676. [Abstract] [Full Text] [PDF]

				J. Soret, N. Bakkour, S. Maire, S. Durand, L. Zekri, M. Gabut, W. Fic, G. Divita, C. Rivalle, D. Dauzonne, et al. Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors PNAS, June 14, 2005; 102(24): 8764 - 8769. [Abstract] [Full Text] [PDF]

				J. Tazi, N. Bakkour, J. Soret, L. Zekri, B. Hazra, W. Laine, B. Baldeyrou, A. Lansiaux, and C. Bailly Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin Derivatives Mol. Pharmacol., April 1, 2005; 67(4): 1186 - 1194. [Abstract] [Full Text] [PDF]

				M. Muraki, B. Ohkawara, T. Hosoya, H. Onogi, J. Koizumi, T. Koizumi, K. Sumi, J.-i. Yomoda, M. V. Murray, H. Kimura, et al. Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks J. Biol. Chem., June 4, 2004; 279(23): 24246 - 24254. [Abstract] [Full Text] [PDF]

				S. Solier, A. Lansiaux, E. Logette, J. Wu, J. Soret, J. Tazi, C. Bailly, L. Desoche, E. Solary, and L. Corcos Topoisomerase I and II Inhibitors Control Caspase-2 Pre-Messenger RNA Splicing in Human Cells Mol. Cancer Res., January 1, 2004; 2(1): 53 - 61. [Abstract] [Full Text] [PDF]